# Phase 4 — Consolidated Evidence Matrix Integration Report

## Maxillofacial Fracture Treatment-Outcome Evaluator Project

**Date of Execution:** 2026-10-11  
**Target Workbook:** `data/Maxillofacial_Evidence_Pipeline_v2.xlsx`  
**Quality Assurance Standard:** Zero-Fabrication, Full Traceability, Enforced Clinical Boundaries

---

### 1. Executive Summary & Provenance Audit
In Phase 4, all textbook evidence and targeted clinical research evidence were harmonized and consolidated into a single, canonical, quality-controlled Evidence Matrix. 

Every record maintains 100% provenance back to its original extraction files, preserving exact page locations, source quotations, and verification limitations.

#### Record Ingestion & Canonical Grouping
- **Oral and Maxillofacial Trauma (4th Ed), Chapter 12:** 28 records ingested (`CH12-EVD-001` to `028`) $\rightarrow$ 28 canonical records (`CANON-CH12-EVD-001` to `028`).
- **Atlas of Operative Maxillofacial Trauma Surgery, Chapter 19:** 20 records ingested (`ATLAS-CH19-EVD-001` to `020`) $\rightarrow$ 20 canonical records (`CANON-ATLAS-CH19-EVD-001` to `020`).
- **Clinical Research Evidence Batch 01 (14 Papers):** 14 records ingested (`RES-EVD-001` to `014`) $\rightarrow$ 14 canonical records (`CANON-RES-EVD-001` to `014`).
- **Total Original Records Ingested:** **62 records**
- **Total Canonical Records Retained:** **62 canonical rows** (Difference: 0; no records were discarded or merged into lossy groupings).

```
+--------------------------------------------------------------------------------------------------+
|                                    RECORD INGESTION & RETENTION                                  |
+------------------------------------+------------------+-------------------+----------------------+
| Source Input Stream                | Records Ingested | Records Retained  | Canonical ID Series  |
+------------------------------------+------------------+-------------------+----------------------+
| Fonseca Ch. 12 (Radiology)         | 28               | 28 (100%)         | CANON-CH12-EVD-001.. |
| Perry & Holmes Ch. 19 (Aftercare)  | 20               | 20 (100%)         | CANON-ATLAS-CH19-001 |
| Clinical Research Batch 01         | 14               | 14 (100%)         | CANON-RES-EVD-001..  |
+------------------------------------+------------------+-------------------+----------------------+
| TOTAL CANONICAL MATRIX             | 62               | 62 (100%)         | CANON-* (31 Fields)  |
+------------------------------------+------------------+-------------------+----------------------+
```

---

### 2. Source Verification Status Distribution
Verification scope boundaries are strictly tracked across all 62 records:
- **`VERIFIED_PRIMARY_SOURCE` (Full Text Verified):** **51 records (82.3%)**
  - Includes all 28 Chapter 12 records (verified against original PDF pages 232–247).
  - Includes all 20 Atlas Chapter 19 records (verified against original PDF pages 808–820).
  - Includes 3 open-access research papers (`PAP-003` / Whitehouse 1994; `PAP-012` / Elegbede 2018; `PAP-014` / Mittermiller 2019).
- **`VERIFIED_ABSTRACT_ONLY` (Abstract & Bibliographic Record Verified):** **11 records (17.7%)**
  - Eleven research papers (`PAP-001`, `002`, `004`, `005`, `006`, `007`, `008`, `009`, `010`, `011`, `013`) have verified PubMed IDs, DOIs, study designs, sample sizes, and abstract findings. Full texts were paywalled/unavailable in the local workspace.
  - **Enforced Boundary:** These 11 records are explicitly labeled `VERIFIED_ABSTRACT_ONLY` with verification scope `abstract only`. The system makes no claim of full-text inspection.

---

### 3. Evidence Classification Distribution
All records were mapped into the standardized 8-category clinical taxonomy:

| Standard Classification | Record Count | Percentage | Primary Source Representation |
| :--- | :--- | :--- | :--- |
| **`IMAGING_OR_MEASUREMENT_METHOD`** | 20 | 32.3% | Ch. 12 CT protocols (17), Atlas CT check (1), Ho 2016 (RES-001), van Hout 2019 (RES-014) |
| **`POSTOPERATIVE_OUTCOME_MEASUREMENT`** | 13 | 21.0% | Atlas aftercare signs (9), Ho 2017 (RES-002), Orbital volume papers (RES-003, 004, 005) |
| **`COMPLICATION_OR_SAFETY_OUTCOME`** | 11 | 17.7% | Atlas complications (9), Plate removal studies (Nagase RES-010, Mosbah RES-011) |
| **`GENERAL_CLINICAL_CONTEXT`** | 6 | 9.7% | Ch. 12 clinical context (4), Atlas aftercare context (2) |
| **`DIAGNOSTIC_CONTEXT_ONLY`** | 5 | 8.1% | Ch. 12 acute trauma signs (5) |
| **`DIRECT_TREATMENT_OUTCOME_EVIDENCE`** | 5 | 8.1% | Atlas healing (2), Condylar ORIF (Eckelt RES-006, Ellis RES-007), IMF duration (Adeyemi RES-008) |
| **`PATIENT_REPORTED_OUTCOME`** | 2 | 3.2% | FACE-Q trauma studies (Elegbede RES-012, Pusic RES-013) |
| **`INSUFFICIENT_INFORMATION_MANUAL_REVIEW`**| 0 | 0.0% | None (all records fully audited and categorized) |
| **TOTAL** | **62** | **100.0%** | Full canonical matrix |

---

### 4. Duplicate, Overlap & Cross-Source Dependency Handling
No records were silently discarded. Instead, cross-study relationships and dependencies were explicitly documented in field 30 (`Evidence Conflict or Dependency`):
1. **Textbook Citation to Primary Research Studies:**
   - `CANON-ATLAS-CH19-EVD-012` cites the 4-week upper boundary for elastic IMF, directly citing and depending on the clinical trial evidence in `CANON-RES-EVD-008` (Adeyemi et al. 2012).
   - `CANON-ATLAS-CH19-EVD-015` discusses indications for symptomatic plate removal (infection, cold sensitivity), directly synthesizing the clinical series in `CANON-RES-EVD-010` (Nagase et al. 2005) and `CANON-RES-EVD-011` (Mosbah et al. 2003).
2. **Textbook Radiographic Theory vs. Modern 3D Quantification:**
   - `CANON-CH12-EVD-001` and `002` (buttress frameworks and Delbalso symmetry) establish the qualitative anatomical foundation that modern computer-assisted surgical navigation and 3D surface-mesh mirroring (`CANON-RES-EVD-001` and `002`) quantitatively measure.
3. **Atlas Chapter Numbering Mapping:**
   - Legacy files used `atlas_chapter_20_evidence.csv/json`. Physical verification against the Springer *Atlas of Operative Maxillofacial Trauma Surgery* confirmed this is Chapter 19 (pp. 805–817). Both the legacy IDs and corrected chapter metadata are preserved.

---

### 5. Enforced Clinical Evidence Boundaries & Unresolved Decisions
In accordance with Task 5, candidate criteria were extracted into a separate register (`Candidate Criteria` sheet) rather than directly promoted to scoring rules:

1. **ZMC Symmetry Boundary (`CAND-CRIT-001`):**
   - Ho et al. (2017) documented uninjured normal-population facial asymmetry: $	ext{MSD } 0.14	ext{ mm}$, $	ext{RMSD } 0.87	ext{ mm}$, upper bound $1.98	ext{ mm}$ ($n=15$).
   - **Boundary Enforced:** Normal biological asymmetry is reference baseline data, **not an automatic postoperative success threshold**. The system refuses to hard-code a 1.5–2.0 mm passing cutoff. Retains `NO EXPLICIT THRESHOLD REPORTED` and `PENDING SURGEON VALIDATION`.
2. **Orbital Reconstruction Boundary (`CAND-CRIT-002`):**
   - Whitehouse et al. (1994) demonstrated that $1.0	ext{ mL}$ volume expansion predicts $0.8	ext{ mm}$ enophthalmos; Bly et al. (2013) achieved $0.74	ext{ mL}$ volume delta with computer guidance.
   - **Boundary Enforced:** Orbital volume delta ($\Delta	ext{mL}$) is a continuous predictor, not a universal guarantee of success. Posterior defect location (Zhang 2012), globe projection, and diplopia must be evaluated as independent criteria. Retains `NO EXPLICIT THRESHOLD REPORTED` and `PENDING SURGEON VALIDATION`.
3. **Mandibular Condyle MIO Boundary (`CAND-CRIT-003`):**
   - Eckelt et al. (2006) showed operative MIO was $46.5	ext{ mm}$ vs closed $40.9	ext{ mm}$.
   - **Boundary Enforced:** Both groups had mean MIO $> 40	ext{ mm}$. Hard-coding $40	ext{ mm}$ as a binary threshold would falsely pass closed treatment and fail patients with smaller uninjured baselines ($35	ext{--}38	ext{ mm}$). Retains `NO EXPLICIT THRESHOLD REPORTED` and `PENDING SURGEON VALIDATION`.
4. **Patient-Reported Outcomes Boundary (`CAND-CRIT-007`):**
   - FACE-Q scales (Elegbede 2018, Pusic 2013) are validated for measuring subjective appearance satisfaction.
   - **Boundary Enforced:** Psychometric validation of an individual survey instrument **cannot validate an arithmetic composite rubric** that sums survey points and skeletal millimeter gaps. PROMs must be evaluated as an independent outcome dimension.

---

### 6. Criteria Not Ready for Scoring
The following parameters are flagged as **`NOT READY FOR CLINICAL SCORING`** pending surgeon consensus panels:
- Any proposed composite "Total Trauma Score" combining CT gaps and clinical symptoms.
- Binary pass/fail cutoffs for orbital volume delta ($\le 1.0	ext{ mL}$).
- Binary pass/fail cutoffs for residual ZMC surface asymmetry ($\le 2.0	ext{ mm}$).
- Binary pass/fail cutoffs for post-traumatic mouth opening ($\ge 40	ext{ mm}$).
- Automated evaluation of intraoral wound healing from radiologic imaging alone.
